| Product Code: ETC067268 | Publication Date: Jun 2021 | Updated Date: Nov 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The import shipments of AI-enabled imaging modalities to Nigeria in 2024 continued to be dominated by top exporters such as China, India, UAE, Germany, and Netherlands. The market concentration, as measured by the HHI, increased significantly from 2023 to 2024, indicating a very high level of concentration among these key exporting countries. The industry experienced a sharp decline in both the CAGR and growth rate from 2023 to 2024, reflecting a challenging market environment for AI-enabled imaging modalities in Nigeria.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria AI-Enabled Imaging Modalities Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria AI-Enabled Imaging Modalities Market - Industry Life Cycle |
3.4 Nigeria AI-Enabled Imaging Modalities Market - Porter's Five Forces |
3.5 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.8 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Modality, 2021 & 2031F |
4 Nigeria AI-Enabled Imaging Modalities Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for advanced healthcare technologies in Nigeria |
4.2.2 Growing prevalence of chronic diseases driving the need for accurate diagnostic tools |
4.2.3 Government initiatives to improve healthcare infrastructure and technology adoption |
4.3 Market Restraints |
4.3.1 Limited awareness and understanding of AI-enabled imaging modalities among healthcare professionals |
4.3.2 High initial investment and operational costs associated with implementing AI imaging technologies in healthcare facilities |
5 Nigeria AI-Enabled Imaging Modalities Market Trends |
6 Nigeria AI-Enabled Imaging Modalities Market, By Types |
6.1 Nigeria AI-Enabled Imaging Modalities Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Software, 2018 - 2027F |
6.1.4 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Hardware, 2018 - 2027F |
6.2 Nigeria AI-Enabled Imaging Modalities Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Image Acquisition, 2018 - 2027F |
6.2.3 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Image Analytics, 2018 - 2027F |
6.2.4 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Detection, 2018 - 2027F |
6.2.5 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Reporting & Communication, 2018 - 2027F |
6.2.6 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Diagnosis & Treatment Decision Report, 2018 - 2027F |
6.2.7 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Others, 2018 - 2027F |
6.3 Nigeria AI-Enabled Imaging Modalities Market, By Therapeutic Application |
6.3.1 Overview and Analysis |
6.3.2 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Cardiology, 2018 - 2027F |
6.3.3 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Oncology, 2018 - 2027F |
6.3.4 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Respiratory, 2018 - 2027F |
6.3.5 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Orthopedics, 2018 - 2027F |
6.3.6 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Others, 2018 - 2027F |
6.4 Nigeria AI-Enabled Imaging Modalities Market, By Modality |
6.4.1 Overview and Analysis |
6.4.2 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Mammography, 2018 - 2027F |
6.4.3 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By X-ray, 2018 - 2027F |
6.4.4 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Ultrasound, 2018 - 2027F |
6.4.5 Nigeria AI-Enabled Imaging Modalities Market Revenues & Volume, By Others, 2018 - 2027F |
7 Nigeria AI-Enabled Imaging Modalities Market Import-Export Trade Statistics |
7.1 Nigeria AI-Enabled Imaging Modalities Market Export to Major Countries |
7.2 Nigeria AI-Enabled Imaging Modalities Market Imports from Major Countries |
8 Nigeria AI-Enabled Imaging Modalities Market Key Performance Indicators |
8.1 Average time reduction in diagnosing medical conditions using AI imaging modalities |
8.2 Percentage increase in accuracy of diagnoses with the use of AI imaging technologies |
8.3 Adoption rate of AI-enabled imaging modalities in healthcare facilities in Nigeria |
8.4 Improvement in patient outcomes and treatment effectiveness with the integration of AI imaging modalities |
9 Nigeria AI-Enabled Imaging Modalities Market - Opportunity Assessment |
9.1 Nigeria AI-Enabled Imaging Modalities Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Nigeria AI-Enabled Imaging Modalities Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 Nigeria AI-Enabled Imaging Modalities Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
9.4 Nigeria AI-Enabled Imaging Modalities Market Opportunity Assessment, By Modality, 2021 & 2031F |
10 Nigeria AI-Enabled Imaging Modalities Market - Competitive Landscape |
10.1 Nigeria AI-Enabled Imaging Modalities Market Revenue Share, By Companies, 2021 |
10.2 Nigeria AI-Enabled Imaging Modalities Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |